1. Editorial introduction

   Nifedipine and Cardioprotection Pages: 875 - 875

2. Introduction: Nifedipine and cardioprotection

   • Antonio Strano

   Nifedipine, Cardioprotection, and Ischemic Heart Disease Pages: 877 - 877

3. Nifedipine and experimental cardioprotection

   • Winifred Gwen Nayler
   • Jianjun Liu
   • Sianna Panagiotopoulos

   Nifedipine, Cardioprotection, and Ischemic Heart Disease Pages: 879 - 885

4. Protective effects of pretreatment with intracoronary nifedipine on myocardial ischemia and dysfunction

   • Ivo Amende
   • Gunhild Herrmann
   • Paul R. Lichtlen

   Nifedipine, Cardioprotection, and Ischemic Heart Disease Pages: 887 - 891

5. Increased coronary tone in exertional angina: The beneficial effects of calcium antagonists

   • Giuseppe Specchia
   • Diego Ardissino
   • Stefano De Servi

   Nifedipine, Cardioprotection, and Ischemic Heart Disease Pages: 893 - 897

6. The combination of slow-release nifedipine and atenolol for stable angina

   • Derek G. Waller
   • Vivian F. Challenor

   Nifedipine, Cardioprotection, and Ischemic Heart Disease Pages: 899 - 904

7. Acute effects of nifedipine versus isosorbide dinitrate on exercise tolerance in patients with isolated coronary artery occlusion and collaterals

   • Francesco Barillà
   • Francesco Pelliccia
   • Attilio Reale

   Nifedipine, Cardioprotection, and Ischemic Heart Disease Pages: 905 - 908

8. Intravenous nifedipine prevents ergonovine-induced myocardial ischemia in patients with stable effort angina

   • Claudio Brunelli
   • Paolo Spallarossa
   • Salvatore Caponnetto

   Nifedipine, Cardioprotection, and Ischemic Heart Disease Pages: 909 - 914

9. Efficacy of slow-release nifedipine on ischemic attacks in patients with variant angina

   • Hirofumi Yasue
   • Yasuhiro Morikami

   Nifedipine, Cardioprotection, and Ischemic Heart Disease Pages: 915 - 918

10. Effects of nifedipine on cardiac function in patients with coronary artery disease evaluated with ambulatory radionuclide monitoring

    • Hirofumi Kambara
    • I. H. Mohiuddin
    • Chuuichi Kawai

    Nifedipine, Cardioprotection, and Ischemic Heart Disease Pages: 919 - 922

11. Effects of nifedipine on left venticular diastolic dysfunction after myocardial infarction

    • Roldano Scognamiglio
    • Giuseppe Fasoli

    Nifedipine, Cardioprotection, and Ischemic Heart Disease Pages: 923 - 928

12. Rationale for treatment of silent myocardial ischemia: Focus on nifedipine

    • Richard W. Nesto

    Nifedipine, Cardioprotection, and Ischemic Heart Disease Pages: 929 - 934

13. Use of nifedipine in hypertension and Raynaud's phenomenon

    • W. Kiowski
    • P. Erne
    • F. R. Bühler

    Nifedipine in Hypertension Pages: 935 - 940

14. Long-term therapy with slow-release nifedipine in essential hypertension

    • Francesco Arrigo
    • Fausto Consolo

    Nifedipine in Hypertension Pages: 941 - 945

15. Hypertension in the elderly

    • Pierre Larochelle

    Nifedipine in Hypertension Pages: 947 - 950

16. Effects of nifedipine on left ventricular diastolic function in hypertension; Echo Doppler study

    • Giancarlo Gambelli
    • Elisabetta Amici
    • Alberto Selvanetti

    Nifedipine in Hypertension Pages: 951 - 955

17. Early regression of left ventricular diastolic abnormalities in hypertensive patients treated with nifedipine

    • I. Sheiban
    • G. Covi
    • A. Lechi

    Nifedipine in Hypertension Pages: 957 - 961

18. Nifedipine interactions in hypertensive patients

    • Antonio Salvetti
    • Armando Magagna
    • Roberto Giovannetti

    Nifedipine in Hypertension Pages: 963 - 968

19. Assessment of left ventricular function after sublingual administration of nifedipine in patients with moderate to severe hypertension

    • Hiroshi Hayashi
    • Masatsugu Iwase
    • Mitsuhiro Yokota

    Nifedipine in Hypertension Pages: 969 - 975

20. Effects of slow-release nifedipine on water-sodium, uric acid, and calcium metabolism, and on aldosterone secretion in patients with essential hypertension

    • Osamu Iimura
    • Kazuaki Shimamoto
    • Hiroaki Komura

    Nifedipine in Hypertension Pages: 977 - 977

21. Renal effects of calcium entry blockers

    • Luis M. Ruilope
    • Jose M. Alcazar

    Nifedipine: Renal Effects Pages: 979 - 982

22. Effect of nifedipine on urinary excretion of calcium and calcium-controlling hormones in essential hypercalciuria

    • Lorenzo Caló
    • Salvatore Cantaro
    • Arturo Borsatti

    Nifedipine: Renal Effects Pages: 983 - 986

23. Effect of nifedipine administration on pulse wave velocity (PWV) of chronic hemodialysis patients—2-year trial

    • Yasushi Saito
    • Kohji Shirai
    • Sho Yoshida

    Nifedipine: Renal Effects Pages: 987 - 990

24. Acute effects of sublingual nifedipine on left ventricular function in hemodialysis hypertensive patients

    • G. Bottero
    • P. Morosetti
    • U. Casciani

    Nifedipine: Renal Effects Pages: 991 - 992

25. Pathogenesis of atherosclerosis: State of the art

    • Christian C. Haudenschild

    Nifedipine and Atherogenesis Pages: 993 - 1004

26. Excessive mural calcium overload — A predominant causal factor in the development of stenosing coronary plaques in humans

    • A. Fleckenstein
    • M. Frey
    • G. Fleckenstein-Grün

    Nifedipine and Atherogenesis Pages: 1005 - 1013

27. Antiatherogenic effects of calcium-channel blockers: Possible mechanisms of action

    • Philip D. Henry

    Nifedipine and Atherogenesis Pages: 1015 - 1020

28. Quantitative analysis of antiatherosclerotic effect of nifedipine in cholesterol-fed rabbits

    • Yhukou Ohta
    • Naoaki Higuchi
    • Toshiaki Sunaga

    Nifedipine and Atherogenesis Pages: 1021 - 1026

29. Influence of nifedipine on experimental arteriosclerosis

    • Andreas M. Knorr
    • Stanislav Kazda

    Nifedipine and Atherogenesis Pages: 1027 - 1031

30. Effects of short- and long-term administration of nifedipine on serum lipoprotein metabolism in patients with mild hypertension

    • Jun Sasaki
    • Kikuo Arakawa

    Nifedipine and Atherogenesis Pages: 1033 - 1035

31. Features of the angiographic evaluation of the INTACT study

    • Stefan Jost
    • Jaap Deckers
    • INTACT study group

    Nifedipine and Atherogenesis Pages: 1037 - 1045

32. Retardation of coronary artery disease in humans by the calcium-channel blocker nifedipine: Results of the INTACT study (International Nifedipine Trial on Antiatherosclerotic Therapy)

    • Paul R. Lichtlen
    • Paul G. Hugenholtz
    • Jaap W. Deckers

    Nifedipine and Atherogenesis Pages: 1047 - 1068